Veledimex

N/A

Report date: 2025/04/20 20:00:03
NME

Base Information

Drug NameVeledimex
Drug Alias Nameveledimex维迪美克veledimexum维来美克INXN-1001 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-12 stimulants
TargetsInterleukin-12
Therapy Area/IndicationsMetastatic breast cancerBrain NeoplasmsMelanoma +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlaunos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlaunos Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerBrain NeoplasmsMelanoma +[6] 

Other Information

ATC CodeN/A
Related LinksKEGG